期刊文献+

加味四逆散对酒精性肝病患者肿瘤坏死因子-α、白细胞介素-6的影响 被引量:3

Effect of Jiawei Sinisan on Serum TNF-αand IL-6 in Patients of Alcohol Liver Diseases
下载PDF
导出
摘要 目的研究加味四逆散治疗酒精性肝病(ALD)的疗效及作用机制。方法以小柴胡颗粒作对照,观察对ALD患者治疗前后的症状、体征、谷丙转氨酶(ALT)、谷草转氨酶(AST)、肿瘤坏死因子(TNF-α)、白细胞介素-6(IL-6)的变化。结果加味四逆散可明显改善患者的症状和体征,显著降低ALT、AST及TNF-α、IL-6水平,总疗效优于小柴胡颗粒。结论加味四逆散对ALD有良好的治疗效果,其通过抗细胞因子TNF-α、IL-6的损伤发挥作用。 Objective To study the mechanism of Jiawei Sinisan (JWSNS) in treating alcohol liver diseases (ALD). Metheds 80 cases of alcohol liver diseases patients were divided into therapy group (with JWSNS) and control group (with Xiaochaihu granules). To observe the changes of symptom, physical sign, ALT, AST, and TNF-α, IL-6 as well before and after therapy respectively. Results JWSNS improved patient's symptom and physical sign, decreased the levels of ALT, AST, TNF-α, IL-6 obviously. Its curative effect was better than Xiaochaihu granules.Conclusions JWSNS has a good curative effect on alcohol liver diseases through resisting hepatic damage from cellular agents TNF-α and IL-6.
出处 《中国中医药信息杂志》 CAS CSCD 2007年第5期10-11,共2页 Chinese Journal of Information on Traditional Chinese Medicine
基金 大同市科技局资助项目(03-2-E51)
关键词 酒精性肝病 加味四逆散 TNF—α IL-6 alcohol liver diseases: Jiawei Sinisan TNF-α IL-6
  • 相关文献

参考文献6

二级参考文献17

  • 1姚桢 见:江正辉 王泰龄主编.酒精性肝病的发病机制:遗传学机制[A].见:江正辉,王泰龄主编.酒精性肝病[C].北京:中国医药科技出版社,2001.20~21.
  • 2Checa JF, Bellentani S, Tiribelli C. Alcohol-induced liver disease: From molecular damage to treatment. Rev Med Chile, 2002, 130: 681-690.
  • 3Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology, 2003, 37: 493-503.
  • 4Monzoni A, Masutti F, Saccoccio G, Bellentani S,Tiribelli C, Giacca M. Genetic determinants of ethanol-induced liver damage. Mol Med, 2001, 7:255 -262.
  • 5Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology, 1997, 26: 143-146.
  • 6Stewart S, Jones D, Day CP. Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends Mol Med, 2001, 7: 408-413.
  • 7Grove J, Daly AK, Bassendine MF, Gilvarry E,Day CP. Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut, 2000, 46: 540-545.
  • 8Jarvelainen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology, 2001, 33: 1148-1153.
  • 9Starkel P, Bishop K, Horsmans Y, Strain AJ. Expression and DNA-binding activity of signal transducer and activator of transcription 3 in alcoholic cirrhosis compared to normal liver and primary biliary cirrhosis in humans. Am J Pathol, 2003,162: 587-596.
  • 10Xu DS, Sorrell MF, Casey CA, Clemens DL, Tuma DJ. Long-term ethanol feeding selectively impairs the attachment of rat perivenous hepatocytes to extracellular matrix substrates. Gastroenterology,1994, 106: 473-479.

共引文献620

同被引文献83

引证文献3

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部